Insider Look at Rabacfosadine (Tanovea) from Shelved Human Drug to Dog Lymphoma Treatment | Dr. Doug Thamm #284 Podcast Por arte de portada

Insider Look at Rabacfosadine (Tanovea) from Shelved Human Drug to Dog Lymphoma Treatment | Dr. Doug Thamm #284

Insider Look at Rabacfosadine (Tanovea) from Shelved Human Drug to Dog Lymphoma Treatment | Dr. Doug Thamm #284

Escúchala gratis

Ver detalles del espectáculo

Acerca de esta escucha

 Dr. Doug Thamm discusses the development and use of Tanovea, a drug for treating lymphoma in dogs. He explains the drug's origins, initially researched as a human cancer therapeutic in collaboration with Gilead Sciences, and its transition to veterinary use. Dr. Thamm provides insights into Tanovea’s application, dosage, and effectiveness compared to the CHOP protocol, as well as its potential side effects and other possible uses in different cancer types like multiple myeloma. The episode also delves into related immunotherapy research and personal reflections from Dr. Thamm, a double cancer survivor, on his career choice in veterinary oncology. Your Voice Matters! If you have a question for our team, or if you want to share your own hopeful dog cancer story, we want to hear from you! Go to https://www.dogcancer.com/ask to submit your question or story, or call our Listener Line at +1 808-868-3200 to leave a question. Related Videos: https://www.youtube.com/watch?v=G0iRyKshzq8 Related Links: Our article on lymphoma: https://www.dogcancer.com/articles/types-of-dog-cancer/lymphoma-in-dogs/ Our article on Tanovea: https://www.dogcancer.com/articles/drugs/tanovea-rabacfosadine-chemotherapy/ Get the facts on dog cancer remission: https://www.dogcancer.com/articles/stats-and-facts/dog-cancer-remission/ Chapters: 00:00 Introduction 00:13 Interview with Dr. Doug Thamm 00:26 The Early Involvement with Tanovea 00:41 Challenges and Discoveries in Drug Development 02:16 Transition from Human to Veterinary Use 02:48 Clinical Trials and Dosage Experiments 06:45 FDA Approval and Practical Use 08:05 Comparing Tanovea and CHOP Protocol 15:23 Exploring Alternative Treatments: Laverdia 18:43 Off-Label Uses and Future Research 23:46 Exploring Tanovea's Effectiveness in Blood Cancers 25:14 Cost Comparison: Tanovea vs. CHOP 26:15 Side Effects of Tanovea 28:47 Pulmonary Fibrosis and Breed-Specific Risks 32:52 Personal Cancer Journeys: Dr. Doug and His Wife 38:23 Debunking Myths About Dog Cancer Treatment 42:24 The Future of Cancer Treatment: Immunotherapy 45:23 Conclusion and Resources Get to know Dr. Doug Thamm: https://www.dogcancer.com/people/doug-Thammm-v-m-d-diplomate-acvim-oncology/ For more details, articles, podcast episodes, and quality education, go to the episode page: https://www.dogcancer.com/podcast/ Learn more about your ad choices. Visit megaphone.fm/adchoices
Todavía no hay opiniones